About the study

The objective of this Post Marketing Surveillance (PMS) is to collect and describe safety and effectiveness profile of Cabometyx™ in real clinical practice setting, according to the approved labelling after the approval of marketing authorization.

Who can take part?

You may be eligible to participate in the study if you meet the following criteria:

Inclusion criteria

1. Patients who meet 'Indications' of label for Cabometyx™ as monotherapy
2. Patients who are treated with Cabometyx™ for the first time according to label for Cabometyx™ as monotherapy
3. Patients who are aged 18 years or older
4. Patients who are willing to provide written consent after being informed of this surveillance

Exclusion criteria

1. Patients who are contraindicated for Cabometyx™ based on Cabometyx™ label

For a full list of inclusion/exclusion criteria, please visit ClinicalTrials.gov

Study locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.